People Briefs

John Guckenheimer, a professor of mathematics and of theoretical and applied mathematics at Cornell University and director of Cornell's Center for Applied Mathematics since 1989, has been named the first director of research programs at the Cornell Theory Center. The Theory Center is one of four National Science Foundation-funded supercomputer centers. It provides advanced computational tools to approximately 2,000 scientists. Guckenheimer, 46, received his B.A. in 1966 from Harvard University

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

John Guckenheimer, a professor of mathematics and of theoretical and applied mathematics at Cornell University and director of Cornell's Center for Applied Mathematics since 1989, has been named the first director of research programs at the Cornell Theory Center. The Theory Center is one of four National Science Foundation-funded supercomputer centers. It provides advanced computational tools to approximately 2,000 scientists. Guckenheimer, 46, received his B.A. in 1966 from Harvard University and his Ph.D. in 1970 from the University of California, Berkeley. In 1973, he came to the University of California, Santa Cruz, as an assistant professor, becoming an associate professor in 1975 and a full professor in 1979. He came to Cornell in 1985.

----

Kip S. Thorne has been named the Richard P. Feynman Professor of Theoretical Physics at the California Institute of Technology. The professorship, established with a $1.5 million gift from a Caltech alumnus, honors the late ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies